74 related articles for article (PubMed ID: 38252684)
1. Tumor-Microenvironment-Activatable Nanoparticle Mediating Immunogene Therapy and M2 Macrophage-Targeted Inhibitor for Synergistic Cancer Immunotherapy.
Hu Y; Nie W; Lyu L; Zhang X; Wang W; Zhang Y; He S; Guo A; Liu F; Wang B; Qian Z; Gao X
ACS Nano; 2024 Jan; 18(4):3295-3312. PubMed ID: 38252684
[TBL] [Abstract][Full Text] [Related]
2. Rational combination of an immune checkpoint inhibitor with CSF1R inhibitor-loaded nanoparticle enhances anticancer efficacy.
Ramesh A; Malik V; Ranjani HA; Smith H; Kulkarni AA
Drug Deliv Transl Res; 2021 Dec; 11(6):2317-2327. PubMed ID: 34365577
[TBL] [Abstract][Full Text] [Related]
3. DNA nanodevice as a multi-module co-delivery platform for combination cancer immunotherapy.
Nie C; Ye J; Jiang JH; Chu X
J Colloid Interface Sci; 2024 Aug; 667():1-11. PubMed ID: 38615618
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy.
Lu Q; Kou D; Lou S; Ashrafizadeh M; Aref AR; Canadas I; Tian Y; Niu X; Wang Y; Torabian P; Wang L; Sethi G; Tergaonkar V; Tay F; Yuan Z; Han P
J Hematol Oncol; 2024 Apr; 17(1):16. PubMed ID: 38566199
[TBL] [Abstract][Full Text] [Related]
5. Cold to Hot: Tumor Immunotherapy by Promoting Vascular Normalization Based on PDGFB Nanocomposites.
Ma S; Tian Z; Liu L; Zhu J; Wang J; Zhao S; Zhu Y; Zhu J; Wang W; Jiang R; Qu Y; Lei J; Zhao J; Jiang T
Small; 2024 Apr; 20(16):e2308638. PubMed ID: 38018295
[TBL] [Abstract][Full Text] [Related]
6. Strengthening the Combinational Immunotherapy from Modulating the Tumor Inflammatory Environment via Hypoxia-Responsive Nanogels.
Luo W; Zeng Y; Song Q; Wang Y; Yuan F; Li Q; Liu Y; Li S; Jannatun N; Zhang G; Li Y
Adv Healthc Mater; 2024 Mar; 13(8):e2302865. PubMed ID: 38062634
[TBL] [Abstract][Full Text] [Related]
7. Intravenous administration of IL-12 encoding self-replicating RNA-lipid nanoparticle complex leads to safe and effective antitumor responses.
Wang Z; Chen Y; Wu H; Wang M; Mao L; Guo X; Zhu J; Ye Z; Luo X; Yang X; Liu X; Yang J; Sheng Z; Lee J; Guo Z; Liu Y
Sci Rep; 2024 Mar; 14(1):7366. PubMed ID: 38548896
[TBL] [Abstract][Full Text] [Related]
8. Dual-targeting biomimetic delivery for anti-glioma activity
Zhao P; Wang Y; Kang X; Wu A; Yin W; Tang Y; Wang J; Zhang M; Duan Y; Huang Y
Chem Sci; 2018 Mar; 9(10):2674-2689. PubMed ID: 29732051
[TBL] [Abstract][Full Text] [Related]
9. Proton Sponge Nanocomposites for Synergistic Tumor Elimination via Autophagy Inhibition-Promoted Cell Apoptosis and Macrophage Repolarization-Enhanced Immune Response.
Duan Y; Zhang W; Ouyang Y; Yang Q; Zhang Q; Zhao S; Chen C; Xu T; Zhang Q; Ran H; Liu H
ACS Appl Mater Interfaces; 2024 Apr; 16(14):17285-17299. PubMed ID: 38539044
[TBL] [Abstract][Full Text] [Related]
10. Exploiting the immune system in hepatic tumor targeting: Unleashing the potential of drugs, natural products, and nanoparticles.
Hsu CY; Mustafa MA; Kumar A; Pramanik A; Sharma R; Mohammed F; Jawad IA; Mohammed IJ; Alshahrani MY; Ali Khalil NAM; Shnishil AT; Abosaoda MK
Pathol Res Pract; 2024 Apr; 256():155266. PubMed ID: 38554489
[TBL] [Abstract][Full Text] [Related]
11. Macrophage colony-stimulating factor and its role in the tumor microenvironment: novel therapeutic avenues and mechanistic insights.
Yi L; Gai Y; Chen Z; Tian K; Liu P; Liang H; Xu X; Peng Q; Luo X
Front Oncol; 2024; 14():1358750. PubMed ID: 38646440
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticle-Mediated Radiotherapy Remodels the Tumor Microenvironment to Enhance Antitumor Efficacy.
Zhen W; Weichselbaum RR; Lin W
Adv Mater; 2023 May; 35(21):e2206370. PubMed ID: 36524978
[TBL] [Abstract][Full Text] [Related]
13. Metallic Nanoparticle-Mediated Immune Cell Regulation and Advanced Cancer Immunotherapy.
Mohapatra A; Sathiyamoorthy P; Park IK
Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834282
[TBL] [Abstract][Full Text] [Related]
14. Advances in tumor immunomodulation based on nanodrug delivery systems.
Wang B; Zhang Y; Yin X
Front Immunol; 2023; 14():1297493. PubMed ID: 38106403
[TBL] [Abstract][Full Text] [Related]
15. Targeted systemic dendrimer delivery of CSF-1R inhibitor to tumor-associated macrophages improves outcomes in orthotopic glioblastoma.
Liaw K; Reddy R; Sharma A; Li J; Chang M; Sharma R; Salazar S; Kannan S; Kannan RM
Bioeng Transl Med; 2021 May; 6(2):e10205. PubMed ID: 34027092
[TBL] [Abstract][Full Text] [Related]
16. Single Atom Catalysts Remodel Tumor Microenvironment for Augmented Sonodynamic Immunotherapy.
Geng B; Hu J; He X; Zhang Z; Cai J; Pan D; Shen L
Adv Mater; 2024 Mar; ():e2313670. PubMed ID: 38490191
[TBL] [Abstract][Full Text] [Related]
17. Highly Active Myeloid Therapy for Cancer.
Fredrich IR; Halabi EA; Kohler RH; Ge X; Garris CS; Weissleder R
ACS Nano; 2023 Oct; 17(20):20666-20679. PubMed ID: 37824733
[TBL] [Abstract][Full Text] [Related]
18. Tumor microenvironment-responsive nanoparticles for cancer theragnostic applications.
Uthaman S; Huh KM; Park IK
Biomater Res; 2018; 22():22. PubMed ID: 30155269
[TBL] [Abstract][Full Text] [Related]
19. The "Heater" of "Cold" Tumors-Blocking IL-6.
Pu W; Ma C; Wang B; Zhu W; Chen H
Adv Biol (Weinh); 2024 May; ():e2300587. PubMed ID: 38773937
[TBL] [Abstract][Full Text] [Related]
20. Melanoma immunotherapy enabled by M2 macrophage targeted immunomodulatory cowpea mosaic virus.
Zhao Z; Chung YH; Steinmetz NF
Mater Adv; 2024 Feb; 5(4):1473-1479. PubMed ID: 38380336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
